chartexchange

ZURA
Zura Bio Limited Class A
stockNASDAQ

At CloseOct 2, 2026 3:59:59 PM EDT
4.12USD-0.483%(-0.02)2,954,783
Pre-marketOct 2, 2026 8:59:30 AM EDT
4.15USD+0.242%(+0.01)
Loading…
Loading…
393.38M
Healthcare
Biotechnology
HQ
San Diego, CA, USA
Previous Close
$4.14
Beta
1.61
52-Week High
$7.44 2026-03-10
52-Week Low
$3.15 2025-10-22
SMA 50
$5.31
SMA 200
$5.32
Avg. Vol 10D
2.30M
Avg. Vol 30D
2.02M
Avg. Vol 90D
1.41M
Relative Vol
1.47
50.75M
0.5500%
2,500,000
18,272
Nov 12, 2026 (38d)
ZURA Profile

zura bio is a clinical-stage biotechnology company advancing zb-168 in alopecia areata and other inflammatory diseases. zb-168 is an anti il7rα inhibitor that has the potential to impact diseases driven by il7 and tslp biological pathways. zura bio aims to develop a portfolio of therapeutic indications for zb-168, and is focused on demonstrating its efficacy, safety, dosing convenience and mechanism of action, initially in alopecia areata. this will build on phase 1b data in type 1 diabetes demonstrating a favourable safety profile and strong biological rationale. zura bio is headquartered in london, uk with team members in the uk and usa.

ZURA Performance
PeriodPriceDateChangeBeta
1W4.102026-09-28+0.12%-1.780
1M6.232026-09-04-34.11%1.299
3M5.362026-07-06-23.41%1.321
6M6.062026-04-06-32.26%1.170
1Y4.172025-10-06-1.56%1.612
2Y4.382024-10-04-6.28%—
5Y30.002023-03-22-86.32%1.448
ZURA Stock Summary

Zura Bio Limited Class A (NASDAQ:ZURA) stock price today is $4.11, and today's volume is 2,954,783. ZURA is down 0.845% today. The 30 day average volume is 2.02M. ZURA market cap is $393.38M with 95.83M shares outstanding.